N/A N=33 Time Restricted Eating for Metabolic and Psychological Optimization
Mild Cognitive Impairment · Obesity
Primary: Change in Memory Composite Rank — 6.22 rank — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=29 Time Restricted Eating on Cancer Risk
Pre-diabetes · Breast Cancer · Time Restricted Feeding
Primary: Change in Advanced Glycation End Products (AGE) as Assessed by Plasma — 5.82; 6.38; 5.82; 6.40 ng/mL
N/A N=6 Time Restricted Eating Pilot - Bariatrics
Time Restricted Feeding
Primary: Weight — -.07 kg
N/A N=81 Pilot Study of Time Restricted Feeding as a Weight Loss Intervention
Obesity
Primary: Changes in Body Weight — -5.1; -6.2 kg
N/A N=12 Time Restricted Eating Outcomes in Multiple Sclerosis
Multiple Sclerosis · Diet, Healthy
Primary: Timed 25-foot Walk Speed — -.3 feet/second — p=.39
N/A N=64 TRE in Type 2 Diabetes (See Food Study 3)
Type2Diabetes
Primary: Change in Glycemic Measures- HbA1c (12w) — -0.22; -0.25 percentage of glycated hemoglobin
N/A N=39 Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study
Cancer Survivorship
Primary: Mean Percent of Days That Participants Adhere to the TRE Dietary Pattern — 90.1 percent of days
N/A N=88 Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
Obesity
Primary: Change in Weight — -3; -3.5; -1.3 Kg
N/A N=37 Intermittent Fasting Adherence and Self Tracking
Hypertension · Obesity
Primary: Adherence to the Intermittent Fasting Regimen, Captured Via Daily Text Message, Over 18 Weeks, Expressed in Days Per Week — 4.7; 5.4 days per week
N/A N=10 Time to Eat Study - Pilot
Overweight
Primary: Number of Participants With Treatment-Emergent Adverse Events as a Measure of Safety and Tolerability — 3 Participants
N/A N=36 Piloting a Family-Based Intervention of Time-Restricted Eating to Treat Obesity
Childhood Obesity
Primary: Change in BMI for Pediatric Participants — -0.7; -0.9 BMI (weight in kg/height in m^2)
N/A N=22 Impact of Meal Timing on Glycemic Profile in Latino Adolescents With Obesity
Pediatric Obesity · Meal Timing
Primary: Change in Insulinogenic Index From Baseline After Test Meal From Venous Sample — 268; 215; 153 Microunits per milliliter
N/A N=50 Time Limited Eating in Adolescents (Time LEAd): a Pilot Study
Obesity, Childhood
Primary: Percent Change in BMI in Excess of the 95th Percentile (%BMIp95) — -3.27; -3.76; -4.85 percent — p=0.4
N/A N=60 The Impact of Intermittent Fasting on Human Metabolism and Cell Autophagy
Excessive Diet Restriction
Primary: Insulin Sensitivity (HOMA-IR) — 0.05; 0.06 no unit
N/A N=100 Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
Coronary Heart Disease · Obesity · Weight Loss
Primary: Body Weight — -4.6; -4.5; 0.3 Percent change at month 12
N/A N=17 TRE With Physical Activity for Weight Management
Pre Diabetes · Overweight and Obesity
Primary: Body Weight Changes Between Week 1 to Week 10 — -2.1; -4.2; -1.3; .1 Percent body weight loss
N/A N=55 Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease
Intermittent Fasting · Metabolic Dysfunction-Associated Fatty Liver Disease
Primary: Transient Elastography-Controlled Attenuation Parameter — 319.5; 343.5; 291.5; 285.0 db/m
N/A N=36 Daytime vs. Delayed Eating Among Obese Individuals
Obesity
Primary: Body Mass (Weight) — -2.1067; -2.1887 kg
N/A N=60 Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism
Fatty Liver Disease · Type 2 Diabetes · Impaired Glucose Regulation
Primary: Change of Liver Fat Content in % — -20.5; -15.5; -7.6; -7.3 absolute fat content change in %
N/A N=17 Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism
Obesity
Primary: Body Mass Changes Between the Daytime vs. Delayed Eating Conditions — -1.1; 0.2 kg
N/A N=50 Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma
Recurrent Glioblastoma
Primary: Progression-free-survival — 20; 16 percentage of participants
N/A N=80 Alternate Day Fasting, Exercise, and NAFLD
Non-Alcoholic Fatty Liver Disease · Obesity
Primary: Change in Hepatic Steatosis — -2.25; -1.3; -5.48; -0.17 liver fat percentage
N/A N=12 The Fasting II Study
Diabetes · Metabolic Diseases
Primary: Difference in Mean Glucose Level Between Baseline and the End of the Sixth Week. — 104.7; 104.5 mg/dL
N/A N=28 Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease
Polycystic Kidney, Autosomal Dominant
Primary: Feasibility to Enroll and Retain Participants — 122 Participants
Phase 1 N=10 Study to Evaluate Potential Food Effects
Healthy
Primary: Cmax — 2567.9; 3568.9 ng/mL
N/A N=105 Effects of Fast Bar on Physiological Fasting
Fasting
Primary: Ketone Area Under the Curve — 1.27; 0.62; 1.17 mg/dL*h
N/A N=10 Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber
Diabetes Mellitus, Type 2
Primary: Overnight Respiratory Exchange Ratio — 0.832; 0.887 ratio
N/A N=77 Intermittent Fasting and a No-Sugar Diet for Long COVID Symptoms
Long Covid19 · Long COVID
Primary: Change in LC-Score, Per Treatment — -10.2; -2.8 Scores on a Scale
N/A N=90 Health, Aging and Later-Life Outcomes
Aging
Primary: Number of Participants That Sustained >10% Caloric Restriction — 7; 12 Participants
N/A N=38 Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Ductal Breast Carcinoma in Situ · Invasive Ductal Breast Carcinoma · Invasive Lobular Breast Carcinoma
Primary: Number of Participants Who Are Adherent to the Diet Restriction — 28 participants